Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44. Epub 2007 Aug 21.

PMID:
17850933
4.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
5.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
6.

Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

González PA, Bueno SM, Riedel CA, Kalergis AM.

Curr Med Chem. 2009;16(34):4609-25. Review.

PMID:
19903147
7.

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Cranage M, Taylor G.

Expert Opin Biol Ther. 2005 Jul;5(7):939-52. Review.

PMID:
16018739
8.

Antigenic diversity of respiratory syncytial viruses and its implication for immunoprophylaxis in ruminants.

Duncan RB Jr, Potgieter LN.

Vet Microbiol. 1993 Nov;37(3-4):319-41. Review.

PMID:
8116189
9.

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.

Murphy BR, Hall SL, Kulkarni AB, Crowe JE Jr, Collins PL, Connors M, Karron RA, Chanock RM.

Virus Res. 1994 Apr;32(1):13-36. Review.

PMID:
8030364
10.
11.

Clinical experience with respiratory syncytial virus vaccines.

Piedra PA.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S94-9. Review.

PMID:
12671459
12.

Respiratory syncytial virus: the virus, the disease and the immune response.

Ogra PL.

Paediatr Respir Rev. 2004;5 Suppl A:S119-26. Review.

PMID:
14980256
13.

Current progress on development of respiratory syncytial virus vaccine.

Chang J.

BMB Rep. 2011 Apr;44(4):232-7. doi: DOI 10.5483/BMBRep.2011.44.4.232. Review.

14.

Respiratory syncytial virus infections: old challenges and new opportunities.

Mejías A, Chávez-Bueno S, Jafri HS, Ramilo O.

Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S189-96, discussion S196-7. Review.

PMID:
16378045
15.
16.

Respiratory syncytial virus (RSV) vaccines--two steps back for one leap forward.

Power UF.

J Clin Virol. 2008 Jan;41(1):38-44. Review.

PMID:
18340669
17.

The CD4 T cell response to respiratory syncytial virus infection.

Christiaansen AF, Knudson CJ, Weiss KA, Varga SM.

Immunol Res. 2014 Aug;59(1-3):109-17. doi: 10.1007/s12026-014-8540-1. Review.

PMID:
24838148
18.

Respiratory syncytial virus vaccine development.

Kahn JS.

Curr Opin Pediatr. 2000 Jun;12(3):257-62. Review.

PMID:
10836163
19.

Identifying targets in the hunt for effective respiratory syncytial virus interventions.

Tayyari F, Hegele RG.

Expert Rev Respir Med. 2012 Apr;6(2):215-22. doi: 10.1586/ers.12.8. Review.

PMID:
22455493
20.

Supplemental Content

Support Center